Cabazitaxel Approved In The USA To Extend Life In Prostate Cancer Victims

Posted on by

Cabazitaxel has been given regulatory approval in the USA and is under consideration by the European Medicines Agency and other global approval committees to be used to extend life expectancy in prostate cancer patients…

View full post on Prostate / Prostate Cancer News From Medical News Today

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

CommentLuv badge